Coronary arterial calcification and thoracic spine mineral density in early menopause

Climacteric

Volumn 14, Issue 4, 2011, Pages 438-444

  Miyabara, Y ^a   Camp, J ^a   Holmes III, D ^a   Lahr, B ^b   Bailey, K ^b   Miller, V M ^a   Kearns, A E ^c  

^a Division of Biomedical Statistics and Informatics   (United States)

^b Mayo Clinic ^*  (United States)

^c MAYO CLINIC   (United States)

Author keywords

Bone specific alkaline phosphatase; Coronary heart disease; Menopause; Osteocalcin; Osteopontin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; MATRIX PROTEIN; OSTEOCALCIN; OSTEOPONTIN; TARTRATE RESIDENT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CORONARY ARTERY CALCIFICATION; EARLY MENOPAUSE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THORACIC SPINE;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCINOSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; THORACIC VERTEBRAE;

EID: 79960461612     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2010.537409     Document Type: Article

References (41)

1. Barrett Connor E. Sex differences in coronary heart disease-why are women so superior? The 1995 Ancel Keys lecture. Circulation 1997;95:252-64
2. Frye MA, Melton LJ III, Cedel SL, et al. Osteoporosis and calcification of the aorta. J Bone Miner Res 1992;19:185-94
3. Schulz E, Arfai K, Liu XD, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 2004;89:4246-53 (Pubitemid 39244420)
4. Tanko LB, Bagger YZ, Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 2003;73:15-20 (Pubitemid 37022074)
5. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PWF. Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study. Calcif Tissue Int 2001;68:271-6 (Pubitemid 32565728)
6. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 2006;259:598-605
7. Farhat GN, Cauley JA, Matthews KA, et al. Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res 2006; 21:1839-46 (Pubitemid 44851559)
8. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998; 62:209-13 (Pubitemid 28127932)
9. Sinnott B, Syed I, Sevrukov A, Barengolts E. Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 2006;78:195-202
10. Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as 'low risk' based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2007;167:2437-42 (Pubitemid 350254902)
11. Bellasi A, Lacey C, Taylor AJ, et al. Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta-and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol 2007;100:409-14 (Pubitemid 47094687)
12. Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009;2:228-39
13. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523-34 (Pubitemid 36951364)
14. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33 (Pubitemid 34761611)
15. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993;103:205-11 (Pubitemid 23360934)
16. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208
17. Farhat GN, Strotmeyer ES, Newman AB, et al. Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: The Health, Aging, and Body Composition study. Calcif Tissue Int 2006;79: 102-11 (Pubitemid 44306167)
18. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001;21:274-301 (Pubitemid 32565495)
19. Manson J, Allison M, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-602 (Pubitemid 46961004)
20. Harman SM, Brinton EA, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005;8:3-12 (Pubitemid 40675116)
21. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92:2163-8
22. Bini A, Mann KG, Kudryk BJ, Schoen FJ. Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19: 1852-61 (Pubitemid 29379914)
23. Dhore CR, Cleutjens JPM, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2003;21:1998-2003
24. Hofbauer LC, Schoppet M. Clinical implications of the osteo-protegerin RANKL/RANK system for bone and vascular diseases. JAMA 2004;292:490-5 (Pubitemid 38988958)
25. Jayachandran M, Litwiller RD, Owen WG, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in recently menopausal women. Am J Physiol Heart Circ Physiol 2008;295:931-8
26. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-32 (Pubitemid 20101575)
27. Camp JJ, Karwoski RA, Stacy MC, et al. A system for the analysis of whole-bone strength from helical CT images. Proc SPIE 2004;5369:74-88
28. Choi SH, An JH, Lim S, et al. Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre-and postmenopausal women. Clin Endocrinol (Oxf) 2009;71:644-51
29. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 2008;93:861-8 (Pubitemid 351398564)
30. Carr JJ, Register TC, Hsu FC, et al. Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone 2008;42:43-52 (Pubitemid 350297171)
31. Fujita M, Urano T, Horie K, et al. Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts. Biochem Biophys Res Commun 2002;299: 222-8 (Pubitemid 35373701)
32. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 2002;143:2349-56 (Pubitemid 34521581)
33. Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 2005;328:688-96 (Pubitemid 40214350)
34. Garnero P, Sornay Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49 (Pubitemid 26076383)
35. Halleen JM, Ylipahkala H, Alatalo SL, et al. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 2002;71:20-5 (Pubitemid 36934772)
36. Rosenquist C, Bonde M, Fledelius C, Qvist P. A simple enzyme-linked-immunosorbent-assay of human osteocalcin. Clin Chem 1994;40:1258-64
37. Bautista DS, Saad Z, Chambers AF, et al. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre-and postmenopausal women. Clin Biochem 1996;29:231-9 (Pubitemid 26142072)
38. Cohen FJ, Eckert S, Mitlak BH. Geographic differences in bone turnover: data from a multinational study in healthy postmeno-pausal women. Calcif Tissue Int 1998;63:277-82 (Pubitemid 28443408)
39. Rogers A, Hannon RA, Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 2000;15:1398-404 (Pubitemid 30413874)
40. Iba K, Takada J, Yamashita T. The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab 2004;22:594-6 (Pubitemid 39517880)
41. Chow JT, Khosla S, Melton LJ 3rd, Atkinson EJ, Camp JJ, Kearns AE. Abdominal aortic calcification, BMD, and bone microstruc-ture: a population-based study. J Bone Miner Res 2008;23:1601-12